Pharmeda Healthcare Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 5 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 9.90 M
- Revenue Growth 67.97%
- Profit Growth 25.25%
- Ebitda 54.24%
- Net Worth 62.18%
- Total Assets -16.90%
About Pharmeda Healthcare
Pharmeda Healthcare Private Limited (PHPL) is a Private Limited Indian Non-Government Company incorporated in India on 13 November 2019 (Five years and three months 2 days old ). Its registered office is in Ghaziabad, Uttar Pradesh, India.
The Corporate was formerly known as Pharmeda Heathcare Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹9.90 M.
Alok Singh, Subhransu Chakraborty, and Ashish Gangwar serve as directors at the Company.
Company Details
-
Location
Ghaziabad, Uttar Pradesh, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U33309UP2019PTC123270
-
Company No.
123270
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
13 Nov 2019
-
Date of AGM
22 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Kanpur
Industry
Who are the key members and board of directors at Pharmeda Healthcare?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ashish Gangwar
|
Director | 18-Jun-2021 | Current |
|
Alok Singh
|
Director | 13-Nov-2019 | Current |
|
Subhransu Chakraborty
|
Director | 13-Nov-2019 | Current |
Financial Performance of Pharmeda Healthcare.
Pharmeda Healthcare Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 67.97% increase. The company also saw a substantial improvement in profitability, with a 25.25% increase in profit. The company's net worth Soared by an impressive increase of 62.18%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Pharmeda Healthcare?
In 2023, Pharmeda Healthcare had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹9.90 M
₹0
Charges Breakdown by Lending Institutions
- Axis Bank Limited : 0.99 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 24 Jan 2024 | Axis Bank Limited | ₹9.90 M | Open |
How Many Employees Work at Pharmeda Healthcare?
Unlock and access historical data on people associated with Pharmeda Healthcare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Pharmeda Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pharmeda Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.